BLISTEX KANK-EZE- benzocaine gel

Land: Vereinigte Staaten

Sprache: Englisch

Quelle: NLM (National Library of Medicine)

Wirkstoff:

BENZOCAINE (UNII: U3RSY48JW5) (BENZOCAINE - UNII:U3RSY48JW5)

Verfügbar ab:

Blistex Inc.

Verabreichungsweg:

BUCCAL

Verschreibungstyp:

OTC DRUG

Berechtigungsstatus:

Export only

Fachinformation

BLISTEX KANK-EZE- BENZOCAINE GEL
BLISTEX INC.
----------
BLIS TEX KANK-EZE
PRINCIPAL DISPLAY PANEL - 5 ML BOTTLE CARTON
BLISTEX KANK-EZE
benzocaine gel
PRODUCT INFORMATION
PRODUCT T YPE
HUMAN OTC DRUG
ITE M CODE (SOURCE )
NDC:10 157-9 411
ROUTE OF ADMINISTRATION
BUCCAL
®
®
Blistex Inc.
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
BENZO CAINE (UNII: U3RSY48 JW5) (BENZOCAINE - UNII:U3RSY48 JW5)
BENZOCAINE
20 g in 10 0 mL
INACTIVE INGREDIENTS
INGREDIENT NAME
STRE NG TH
PO LYETHYLENE GLYCO L 3 0 0 (UNII: 56 55G9 Y8 AQ)
TANNIC ACID (UNII: 28 F9 E0 DJY6 )
DIMETHYL ISO SO RBIDE (UNII: SA6 A6 V432S)
BENZYL ALCO HO L (UNII: LKG8 49 4WBH)
CASTO R O IL (UNII: D5340 Y2I9 G)
ETHYLCELLULO SES (UNII: 7Z8 S9 VYZ4B)
CETYLPYRIDINIUM CHLO RIDE (UNII: D9 OM4SK49 P)
SACCHARIN (UNII: FST46 7XS7D)
ALCO HO L (UNII: 3K9 9 58 V9 0 M)
PRO PYLENE GLYCO L (UNII: 6 DC9 Q16 7V3)
O LETH-10 (UNII: JD79 7EF70 J)
BENZO IN RESIN (UNII: GK21SBA74R)
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START
DATE
MARKETING END
DATE
1
NDC:10 157-9 411-
1
1 in 1 CARTON
11/20 /20 12
1
5 mL in 1 BOTTLE, GLASS; Type 0 : No t a Co mbinatio n
Pro duc t
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH CITATION
MARKE TING START DATE
MARKE TING END DATE
EXPORT ONLY
11/20 /20 12
LABELER -
Blistex Inc. (005126354)
ESTABLISHMENT
NAME
AD D RE S S
ID/FEI
BUSINE SS OPE RATIONS
Blistex Inc.
0 0 5126 354
MANUFACTURE(10 157-9 411)
Revised: 6/2016